doi: 10.1111/j.1365-2125.2009.03555.x.
Severe toxicity related to a pharmacokinetic interaction between docetaxel and ritonavir in HIV-infected patients
- PMID: 20078618
- PMCID: PMC2830603
- DOI: 10.1111/j.1365-2125.2009.03555.x
Item in Clipboard
Severe toxicity related to a pharmacokinetic interaction between docetaxel and ritonavir in HIV-infected patients
Br J Clin Pharmacol.
2010 Jan.
No abstract available
Similar articles
-
Possible pharmacokinetic interaction involving ritonavir and docetaxel in a patient with Kaposi's sarcoma.AIDS. 2008 Jun 19;22(10):1237-9. doi: 10.1097/QAD.0b013e328300ca98. AIDS. 2008. PMID: 18525276 No abstract available.
-
Once-daily indinavir plus ritonavir: preliminary results of the PIPO study.AIDS. 2000 Nov 10;14(16):2621-3. doi: 10.1097/00002030-200011100-00032. AIDS. 2000. PMID: 11101081 Clinical Trial. No abstract available.
-
Combination antiretroviral therapy (cART) component ritonavir significantly alters docetaxel exposure.Cancer Chemother Pharmacol. 2014 Apr;73(4):729-36. doi: 10.1007/s00280-014-2399-7. Epub 2014 Feb 2. Cancer Chemother Pharmacol. 2014. PMID: 24488374 Free PMC article.
-
Amprenavir or fosamprenavir plus ritonavir in HIV infection: pharmacology, efficacy and tolerability profile.Drugs. 2005;65(5):633-59. doi: 10.2165/00003495-200565050-00005. Drugs. 2005. PMID: 15748098 Review.
-
Heat-stable ritonavir tablets: a new formulation of a pharmacokinetic enhancer for HIV.Expert Opin Pharmacother. 2011 Jan;12(1):141-8. doi: 10.1517/14656566.2011.542151. Epub 2010 Dec 10. Expert Opin Pharmacother. 2011. PMID: 21142696 Review.
Cited by
-
Use of antineoplastic agents in patients with cancer who have HIV/AIDS.Lancet Oncol. 2011 Sep;12(9):905-12. doi: 10.1016/S1470-2045(11)70056-0. Epub 2011 May 12. Lancet Oncol. 2011. PMID: 21570912 Free PMC article. Review.
-
Potential use of multikinase inhibitors in immunosuppressed patients with malignancies including thyroid cancer.Cancer Med. 2022 Oct;11 Suppl 1(Suppl 1):10-16. doi: 10.1002/cam4.5106. Cancer Med. 2022. PMID: 36202608 Free PMC article. Review.
-
Safety of raltegravir-based antiretroviral therapy in HIV-infected patients receiving multi-kinase inhibitors.Invest New Drugs. 2017 Apr;35(2):247-249. doi: 10.1007/s10637-016-0405-0. Epub 2016 Nov 12. Invest New Drugs. 2017. PMID: 27838867
-
P-glycoprotein- and organic anion-transporting polypeptide-mediated transport of periplocin may lead to drug-herb/drug-drug interactions.Drug Des Devel Ther. 2014 May 9;8:475-83. doi: 10.2147/DDDT.S61024. eCollection 2014. Drug Des Devel Ther. 2014. PMID: 24872678 Free PMC article.
-
Important Drug-Drug Interactions in HIV-Infected Persons on Antiretroviral Therapy: An Update on New Interactions Between HIV and Non-HIV Drugs.Curr Infect Dis Rep. 2012 Feb;14(1):67-82. doi: 10.1007/s11908-011-0229-1. Curr Infect Dis Rep. 2012. PMID: 22125049
References
-
- Clarke SJ, Rivory LP. Clinical pharmacokinetics of docetaxel. Clin Pharmacokinet. 1999;36:99–114. - PubMed
-
- Alexandre J, Rey E, Girre V, Grabar S, Tran A, Montheil V, Rabillon F, Dieras V, Jullien V, Herait P, Pons G, Treluyer JM, Goldwasser F. Relationship between cytochrome 3A activity, inflammatory status and the risk of docetaxel-induced febrile neutropenia: a prospective study. Ann Oncol. 2007;18:168–72. - PubMed
-
- Zeldin RK, Petruschke RA. Pharmacological and therapeutic properties of ritonavir boosted protease inhibitor therapy in HIV-infected patients. J Antimicrob Chemother. 2004;53:4–9. - PubMed
-
- Lim ST, Tupule A, Espina BM, Levine AM. Weekly docetaxel is safe and effective in the treatment of advanced-stage acquired immunodeficiency syndrome-related Kaposi sarcoma. Cancer. 2005;103:417–21. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
